Ra Capital Management reported a 9.9% stake in Contineum Therapeutics CTNM · 2,122,000 sh · passive holder

Trade details

Type: 5% stake report
Report: 13G passive
Stake: 9.9%
Last report: First report
Shares held: 2,122,000 sh
Class: Class A Common Stock, $0.001 par value per share
Stock: Contineum Therapeutics CTNM
Holder: Ra Capital Management
Event date: 25/07/18
Filed: 25/07/25

First 5%+ report · 9.9% stake

Contineum Therapeutics trades, last 26 weeks

What else happened in Contineum Therapeutics around then

Filed or reported within 30 days of the trade day · 25/06/18~25/08/17

Ra Capital Management's other 5% stake reports

Ra Capital Management
5% stakeCorbus Pharmaceuticals Holdings
5% stake
Corbus Pharmaceuticals Holdings
CRBP
9.9% stake
1,914,788 sh
9.9% stake
Filed 09/30
Ra Capital Management
5% stakeBetterLife Pharma
5% stake
BetterLife Pharma
BETRF
9% stake
55,420,000 sh
9% stake
Filed 09/22
Ra Capital Management
5% stakeSionna Therapeutics
5% stake
Sionna Therapeutics
SION
14.3% stake
6,476,193 sh
14.3% stake
Filed 09/21
Ra Capital Management
5% stakeTyra Biosciences
5% stake
Tyra Biosciences
TYRA
19.9% stake
14,130,492 sh
19.9% stake
Filed 09/17
Ra Capital Management
5% stakeJatt III Acquisition
5% stake
Jatt III Acquisition
JTTT
5.1% stake
450,000 sh
5.1% stake
Filed 09/03